APOE and Alzheimer disease: A longitudinal study showed that APOE ε4 non-carriers with AD, have cholesterol metabolism dysfunction and functional harm with raised HDL-cholesterol levels, possibly due to lower availability of lipids to neuronal membranes (de Oliveira et al., 2017).